Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.
暂无分享,去创建一个
Yan Li | M Neale Weitzmann | M. Weitzmann | D. Dillehay | Karen Strait | Dirck L Dillehay | Yan Li | K. Strait
[1] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.
[2] Shi Wei,et al. IL-1 mediates TNF-induced osteoclastogenesis. , 2005, The Journal of clinical investigation.
[3] A. Tosteson,et al. Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] Y. Abu-Amer,et al. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. , 2004, The Journal of biological chemistry.
[5] S. Makarov. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. , 2000, Molecular medicine today.
[6] C. Moran,et al. Mortality and serum urea and electrolytes on admission for hip fracture patients. , 2006, Injury.
[7] S. Takeshita,et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.
[8] A. Leonardi,et al. Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.
[9] V. Amarnath,et al. Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[10] J. Rubin,et al. Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NFκB Pathways* , 2006, Journal of Biological Chemistry.
[11] J. Rubin,et al. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. , 2005, American journal of physiology. Endocrinology and metabolism.
[12] Wei-Ping Qian,et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Lacey,et al. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells , 1999 .
[14] M. Nanes,et al. Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF‐κB , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] G. Roodman,et al. SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. , 2007, Blood.
[16] M. Korabiowska,et al. Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR - double knockout mice. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[17] L. Xing,et al. Required and nonessential functions of nuclear factor-kappa B in bone cells. , 1999, Bone.
[18] T. Chambers,et al. The role of reactive oxygen intermediates in osteoclastic bone resorption. , 1995, Biochemical and biophysical research communications.
[19] A. Samadi,et al. Chronic treatment with agents that stabilize cytosolic IκB-α enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch , 2005, Neurobiology of Disease.
[20] E. Mazzon,et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation , 2002, British journal of pharmacology.
[21] R. Pacifici,et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. , 2000, The Journal of clinical investigation.
[22] A. Mukherjee,et al. Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[23] J. Caamaño,et al. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. , 1997, Nature medicine.
[24] C. Murphy,et al. TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL. , 2002, Endocrinology.